Abstract
Biopharmaceutics is the field that investigates and describes everything that happens with a medicinal product and the active substance between the moment of administration, the moment it exerts its action and the moment it is eliminated from the body. Biopharmaceutics connects the physico-chemical properties of an active substance and its dosage form with its action and fate in the living organism. It encompasses pharmacokinetics, pharmacodynamics and drug delivery technology. The route of administration, the way the active substance is released from the dosage form, and the way the body handles (absorbs, distributes, metabolises and excretes) the active substance, together determine its (duration of) action, its efficacy and the occurrence of adverse effects. This chapter explains general principles of biopharmaceutics and their implications on the design of medicines. It describes the general biopharmaceutical principles that are relevant to the major routes of administration: parenteral, oromucosal, oral, rectal, dermal, nasal, pulmonary and ocular. Topics discussed include solubility and dissolution, bioavailability, partition coefficient and pH partition theory, the biopharmaceutical classification system (BCS), excipient-, food-, drug- and herb-drug interactions, first-pass effects and drug metabolism, bioequivalence and new developments in the field of advanced drug delivery systems.
Based upon the chapter ‘Biofarmacie’ by Erik Frijlink, Farida Kadir and Herman Vromans in the 2009 edition of Recepteerkunde.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Benet LZ (2013) The role of BCS (biopharmaceutics classification system) and BDDCS (biopharmaceutics drug disposition classification system) in drug development. J Pharm Sci 102(1):34–42
Karalis V, Macheras P (2012) Current regulatory approaches of bioequivalence testing. Expert Opin Drug Metab Toxicol 8(8):929–942
Committee for medicinal products for human use (CHMP) (2010) Guidelines on the investigation of bioequivalence. European Medicines Agency, London. www.ema.europa.eu. Most recent version
Fleisher D, Li C, Zhou Y, Pao LH, Karim A (1999) Drug, meal and formulation interactions influencing drug absorption after oral administration; clinical implications. Clin Pharmacokinet 36:233–254
König J, Müller F, Fromm MF (2013) Transporters and drug-drug interactions: important determinants of drug disposition and effects. Pharmacol Rev 65(7):944–966
Gouws C, Steyn D, Du Plessis L, Steenekamp J, Hamman JH (2012) Combination therapy of Western drugs and herbal medicines: recent advances in understanding interactions involving metabolism and efflux. Expert Opin Drug Metab Toxicol 8(8):973–984
Hermann R, Von Richter O (2012) Clinical evidence of herbal drugs as perpetrators of pharmacokinetic drug interactions. Planta Med 78:1458–1477
Yáñez JA, Remsberg CM, Sayre CL, Forrest ML, Davies NM (2011) Flip-flop pharmacokinetics - challenges and opportunities during drug development. Ther Deliv 2(5):643–672
Li H, Yu Y, Dana SF, Li B, Lee C-Y, Kang L (2013) Novel engineered systems for oral, mucosal and transdermal drug delivery. J Drug Target 21(7):611–629
Thomas BJ, Finnin BC (2004) The transdermal revolution. Drug Discov Today 16(9):697–703
Prausnitz MR, Langer R (2008) Transdermal drug delivery. Nat Biotechnol 26(11):1261–1268
Amorij JP, Hinrichs WLJ, Frijlink HW, Wilschut JC, Huckriede A (2010) Needle-free influenza vaccination. Lancet Infect Dis 10:699–711
Tonnis WF, Lexmond AJ, Frijlink HW, De Boer AH, Hinrichs WLJ (2013) Devices and formulations for pulmonary vaccination. Expert Opin Drug Deliv 10(10):1383–1397
Ballantyne A, Dhillon S (2013) Trastuzumab emtansine: first global approval. Drugs 73(7):755–765
Gaudet D, Methot J, Dery S, Drisson D, Essembre C, Tremblay G, Tremblay K, de Wal J, Twisk J, van den Bulk N, Sier-Ferreira V, van Deventer S (2013) Efficacy and long-term safety of Alipogene tiparvovec (AVV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trail. Gener Ther 20(4):361–369
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 KNMP and Springer International Publishing Switzerland
About this chapter
Cite this chapter
Frijlink, E., Touw, D., Woerdenbag, H. (2015). Biopharmaceutics. In: Bouwman-Boer, Y., Fenton-May, V., Le Brun, P. (eds) Practical Pharmaceutics. Springer, Cham. https://doi.org/10.1007/978-3-319-15814-3_16
Download citation
DOI: https://doi.org/10.1007/978-3-319-15814-3_16
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-15813-6
Online ISBN: 978-3-319-15814-3
eBook Packages: MedicineMedicine (R0)